Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or Schizophrenia

A Safety/Tolerance Study to Evaluate a New Titration Scheme in Patients With Bipolar I Disorder or Schizophrenia

This is a single-center open-label study to be conducted in the United States in subjects with bipolar I disorder or schizophrenia.

Inclusion Criteria:

• Male or female patients 18 to 65 years of age (inclusive)
• Diagnosed with either schizophrenia or bipolar I disorder, manic or mixed type as per DSM-V criteria
• Symptomatically stable within the past two months

Exclusion Criteria:

• Exposure to any investigational medication, including placebo, in the past 60 days
• Non-response to clozapine